NRTI

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 550 Broad Street
  • Suite 1212
  • Newark, NJ 07102

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2015 10-Q
CIK 0000072170
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2000
Employees 11 a/o Dec 31, 2014
Company Officers/Contacts
Michael C. James CEO, CFO
James Kras COO, IR, President
Company Directors
Michael C. James Chairman
James Delucia
James Kras
Company Notes
  • Formerly=Millennium Biotechnologies Group, Inc. until 5-2010
  • Formerly=Regent Group, Inc. until 4-02
  • Formerly=NMC Corp. until 9-97
Service Providers
Accounting/Auditing Firm
Friedman LLP
301 Lippincott Drive
4th Floor
Marlton, NJ, 08053
United States

Legal Counsel
Silverman Shin Byrne & Gilchrest
381 Park Avenue
New York, NY, 10016
United States

Investor Relations Firm
KARV Communications
590 Madison Avenue
New York, NY, 10022
United States

NRTI Security Details
Share Structure
Market Value1 $195,860 a/o Dec 07, 2016
Authorized Shares 2,000,000,000 a/o Nov 30, 2016
Outstanding Shares 1,958,595,468 a/o Nov 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 561 a/o Apr 15, 2015
Short Selling Data
Short Interest 241 (0%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security